Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
![]() |
Vaccine protection against Zika virus from BrazilNature (London), 2016-08, Vol.536 (7617), p.474-478 [Peer Reviewed Journal]COPYRIGHT 2016 Nature Publishing Group ;COPYRIGHT 2016 Nature Publishing Group ;Copyright Nature Publishing Group Aug 25, 2016 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/nature18952 ;PMID: 27355570 ;CODEN: NATUASFull text available |
2 |
Material Type: Article
|
![]() |
Inactivated Rabies Virus-Based Ebola Vaccine Preserved by Vaporization Is Heat-Stable and Immunogenic Against Ebola and Protects Against Rabies ChallengeThe Journal of infectious diseases, 2019-11, Vol.220 (9), p.1521-1528 [Peer Reviewed Journal]Published by Oxford University Press for the Infectious Diseases Society of America 2019. ;Published by Oxford University Press for the Infectious Diseases Society of America 2019. 2019 ;ISSN: 0022-1899 ;EISSN: 1537-6613 ;DOI: 10.1093/infdis/jiz332 ;PMID: 31374568Full text available |
3 |
Material Type: Article
|
![]() |
Immunogenicity and safety of MenACWY-TT, a meningococcal conjugate vaccine, co-administered with routine childhood vaccine in healthy infants: A phase III, randomized studyVaccine, 2018-06, Vol.36 (28), p.4102-4111 [Peer Reviewed Journal]2018 ;Copyright © 2018. Published by Elsevier Ltd. ;Copyright Elsevier Limited Jun 27, 2018 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2018.05.046 ;PMID: 29784470Full text available |
4 |
Material Type: Article
|
![]() |
Immunogenicity, safety, and tolerability of the measles-vectored chikungunya virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled phase 2 trialThe Lancet (British edition), 2018-12, Vol.392 (10165), p.2718-2727 [Peer Reviewed Journal]2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Dec 22, 2018 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)32488-7 ;PMID: 30409443Full text available |
5 |
Material Type: Article
|
![]() |
BNT162b vaccines protect rhesus macaques from SARS-CoV-2Nature (London), 2021-04, Vol.592 (7853), p.283-289 [Peer Reviewed Journal]Copyright Nature Publishing Group Apr 8, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03275-y ;PMID: 33524990Full text available |
6 |
Material Type: Article
|
![]() |
Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: A randomized clinical trialVaccine, 2016-01, Vol.34 (3), p.313-319 [Peer Reviewed Journal]Elsevier Ltd ;2015 Elsevier Ltd ;Copyright © 2015 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jan 12, 2016 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2015.11.056 ;PMID: 26657184Full text available |
7 |
Material Type: Article
|
![]() |
Immunogenicity and safety of a combined measles, mumps, rubella and varicella live vaccine (ProQuad® ) administered concomitantly with a booster dose of a hexavalent vaccine in 12–23-month-old infantsVaccine, 2015-05, Vol.33 (20), p.2379-2386 [Peer Reviewed Journal]Elsevier Ltd ;2015 Elsevier Ltd ;Copyright © 2015 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited May 11, 2015 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2015.02.070 ;PMID: 25765966Full text available |
8 |
Material Type: Article
|
![]() |
Immunogenicity of a combination vaccine containing diphtheria toxoid, tetanus toxoid, three-component acellular pertussis, hepatitis B, inactivated polio virus, and Haemophilus influenzae type b when given concomitantly with 13-valent pneumococcal conjugate vaccineVaccine, 2011-08, Vol.29 (35), p.6042-6048 [Peer Reviewed Journal]Elsevier Ltd ;2011 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2011 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Aug 11, 2011 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2011.06.026 ;PMID: 21704105 ;CODEN: VACCDEFull text available |
9 |
Material Type: Article
|
![]() |
Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineNew England Journal of Medicine, 2020-12, Vol.383 (27), p.2603-2615 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;COPYRIGHT 2020 Massachusetts Medical Society ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2020 Massachusetts Medical Society. All rights reserved. 2020 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2034577 ;PMID: 33301246Digital Resources/Online E-Resources |
10 |
Material Type: Article
|
![]() |
Relative Effectiveness of Influenza Vaccines Among the United States Elderly, 2018–2019The Journal of infectious diseases, 2020-06, Vol.222 (2), p.278-287 [Peer Reviewed Journal]Published by Oxford University Press for the Infectious Diseases Society of America 2020. 2020 ;Published by Oxford University Press for the Infectious Diseases Society of America 2020. ;ISSN: 0022-1899 ;EISSN: 1537-6613 ;DOI: 10.1093/infdis/jiaa080 ;PMID: 32100009Full text available |
11 |
Material Type: Article
|
![]() |
The COVID-19 vaccine development landscapeNature reviews. Drug discovery, 2020-05, Vol.19 (5), p.305-306 [Peer Reviewed Journal]COPYRIGHT 2020 Nature Publishing Group ;Nature 2020. ;ISSN: 1474-1776 ;EISSN: 1474-1784 ;DOI: 10.1038/d41573-020-00073-5 ;PMID: 32273591Full text available |
12 |
Material Type: Article
|
![]() |
Effectiveness and safety of immunization with live-attenuated and inactivated vaccines for pediatric liver transplantation recipientsVaccine, 2015-03, Vol.33 (12), p.1440-1445 [Peer Reviewed Journal]2015 ;Copyright © 2015. Published by Elsevier Ltd. ;Copyright Elsevier Limited Mar 17, 2015 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2015.01.075 ;PMID: 25665961Full text available |
13 |
Material Type: Article
|
![]() |
The Delay in the Licensing of Protozoal Vaccines: A Comparative HistoryFrontiers in immunology, 2020-03, Vol.11, p.204-204 [Peer Reviewed Journal]Copyright © 2020 Palatnik-de-Sousa and Nico. ;COPYRIGHT 2020 Frontiers Research Foundation ;Copyright © 2020 Palatnik-de-Sousa and Nico. 2020 Palatnik-de-Sousa and Nico ;ISSN: 1664-3224 ;EISSN: 1664-3224 ;DOI: 10.3389/fimmu.2020.00204 ;PMID: 32210953Full text available |
14 |
Material Type: Article
|
![]() |
Potential for Maternally Administered Vaccine for Infant Group B StreptococcusThe New England journal of medicine, 2023-07, Vol.389 (3), p.215-227 [Peer Reviewed Journal]Copyright © 2023 Massachusetts Medical Society. All rights reserved. ;Copyright © 2023 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2116045 ;PMID: 37467497Full text available |
15 |
Material Type: Article
|
![]() |
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variantsNature (London), 2021-04, Vol.592 (7855), p.616-622 [Peer Reviewed Journal]COPYRIGHT 2021 Nature Publishing Group ;Copyright Nature Publishing Group Apr 22, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03324-6 ;PMID: 33567448Full text available |
16 |
Material Type: Article
|
![]() |
Broad and potent immune responses to a low dose intradermal HIV-1 DNA boosted with HIV-1 recombinant MVA among healthy adults in TanzaniaVaccine, 2011-10, Vol.29 (46), p.8417-8428 [Peer Reviewed Journal]Elsevier Ltd ;2011 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2011 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Oct 26, 2011 ;ISSN: 0264-410X ;ISSN: 1873-2518 ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2011.08.001 ;PMID: 21864626 ;CODEN: VACCDEFull text available |
17 |
Material Type: Article
|
![]() |
A Phase I, dose-escalation trial in adults of three recombinant attenuated Salmonella Typhi vaccine vectors producing Streptococcus pneumoniae surface protein antigen PspAVaccine, 2013-10, Vol.31 (42), p.4874-4880 [Peer Reviewed Journal]Elsevier Ltd ;2013 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2013 Elsevier Ltd. All rights reserved. ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2013.07.049 ;PMID: 23916987 ;CODEN: VACCDEFull text available |
18 |
Material Type: Article
|
![]() |
Safety and immunogenicity of a Sf9 insect cell-derived respiratory syncytial virus fusion protein nanoparticle vaccineVaccine, 2013-01, Vol.31 (3), p.524-532 [Peer Reviewed Journal]Elsevier Ltd ;2012 Elsevier Ltd ;2014 INIST-CNRS ;Copyright © 2012 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jan 7, 2013 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2012.11.009 ;PMID: 23153449 ;CODEN: VACCDEFull text available |
19 |
Material Type: Article
|
![]() |
Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis -based vaccine to enter clinical trialsVaccine, 2013-10, Vol.31 (42), p.4867-4873 [Peer Reviewed Journal]Elsevier Ltd ;2013 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2013 Elsevier Ltd. All rights reserved. ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2013.07.051 ;PMID: 23965219 ;CODEN: VACCDEFull text available |
20 |
Material Type: Article
|
![]() |
Confronting the barriers to develop novel vaccines against brucellosisExpert review of vaccines, 2011-09, Vol.10 (9), p.1291-1305 [Peer Reviewed Journal]Expert Reviews Ltd 2011 ;COPYRIGHT 2011 Expert Reviews Ltd. ;ISSN: 1476-0584 ;EISSN: 1744-8395 ;DOI: 10.1586/erv.11.110 ;PMID: 21919619Full text available |